|  | Conditions & Treatments | Poisoning

Molybdenum Toxicity in Humans: Evidence, Safety Limits & Key Facts

Human Toxicity Profile

No known toxic effects of molybdenum have been documented in humans, even at very high exposures. This conclusion is based on occupational studies, dietary intake data, and controlled supplementation trials.

Key Evidence Points

  • Animal ≠ Human: While high doses cause toxicity in animals (e.g., growth retardation, anemia, joint deformities in ruminants), these effects have not been replicated in humans. Interspecies differences in metabolism and copper interaction limit extrapolation.
  • Non-genotoxic, non-carcinogenic, non-teratogenic: Molybdenum does not cause DNA mutations, cancer, or birth defects in available human and animal data.
  • Essential nutrient: Molybdenum is a cofactor for vital enzymes (xanthine oxidase, aldehyde oxidase, sulfite oxidase, mitochondrial amidoxime-reducing component). Deficiency is rare but documented in genetic disorders and long-term TPN without molybdenum.

Dietary Intake & Upper Limits

GroupRDA (μg/day)UL (μg/day)
Adults 19+452,000
Pregnancy/Lactation502,000
Children 1–1817–43300–1,700

UL = Tolerable Upper Intake Level (Institute of Medicine). No adverse effects reported at intakes up to UL.

High-Exposure Scenarios

  • Occupational (mining, metallurgy): Inhalation of molybdenum dust/fumes → transient respiratory irritation, elevated serum uric acid (molybdenum inhibits xanthine oxidase), but no chronic disease established.
  • Supplements: Doses up to 1,500 μg/day used in trials for Wilson's disease, cancer prevention, etc., without serious toxicity.
  • Environmental: High soil/water molybdenum areas (e.g., parts of Armenia) → high intake (10–15 mg/day) associated with gout-like symptoms and elevated uric acid, but not overt toxicity.

Interaction with Copper

High molybdenum intake (especially as tetrathiomolybdate) can impair copper absorption, leading to secondary copper deficiency (anemia, neutropenia, neuropathy). This is the primary mechanism of toxicity in ruminants and a theoretical concern in humans at very high doses.

Practical Takeaway

  • Normal dietary intake (legumes, grains, nuts, leafy veg, organ meats) provides 80–300 μg/day—well within safe range.
  • Supplementation beyond RDA is unnecessary for most people.
  • Patients on tetrathiomolybdate therapy require copper monitoring.
  • No evidence supports molybdenum toxicity from food or standard supplements in healthy humans.

Poisoning - Related Articles